During the past decade, Apollo Speciality Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 11 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Apollo Speciality Hospital" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Helsinn Healthcare SA" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Speciality Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Apollo Speciality Hospital" are "Breast Cancer" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Crohn's Disease" (2 trials), "Heart Failure" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Apollo Speciality Hospital" in a lesser frequency.

Most popular intervention types in "Apollo Speciality Hospital" are "Drug" (18 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (4 trials), "Dexamethasone" (2 trials), "Empagliflozin" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Speciality Hospital" are 15 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Apollo Speciality Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Apollo Speciality Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Speciality Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".